Najnowsze artykuły: IONS Up on FDA's Breakthrough Tag for ION582 in Angelman SyndromeIonis Pharmaceuticals IONS announced that the FDA has granted the Breakthrough Therapy designation to its pipeline candidate, ION582, for the treatment of Angelman syndrome (AS), a rare neurological ...